Ipratropium Bromide
Brand name: Ipratropium Bromide
Rank #269 of 500 drugs by total cost
$45.4M
Total Cost
656,249
Total Claims
$45.4M
Total Cost
19,700
Prescribers
$69
Cost per Claim
213,021
Beneficiaries
934,881
30-Day Fills
$2,306
Avg Cost/Provider
33
Avg Claims/Provider
About Ipratropium Bromide
Ipratropium Bromide (sold as Ipratropium Bromide) was prescribed 656,249 times by 19,700 Medicare Part D providers in 2023, costing the program $45.4M. At $69 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 266 | Darunavir (Prezista) | $46.0M | 21,793 |
| 267 | C1 Esterase Inhibitor (Haegarda) | $45.8M | 894 |
| 268 | Alectinib Hcl (Alecensa) | $45.7M | 2,686 |
| 269 | Ipratropium Bromide (Ipratropium Bromide) | $45.4M | 656,249 |
| 270 | Amantadine Hcl (Amantadine) | $45.2M | 173,840 |
| 271 | Insulin Nph Human Isophane (Humulin N) | $44.9M | 172,714 |
| 272 | Bosutinib (Bosulif) | $44.9M | 2,962 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology